✦ LIBER ✦

A Multicenter, Single-Arm Phase II Study of Pemetrexed Plus Doxorubicin Administered Every 21 Days in Patients With Advanced Breast Cancer

✍ Scribed by Miguel Martin; Maria Blasinska-Morawiec; J. Fernando Salas; Silvia Falcon; Janusz Rolski; Bruno L. Ferrari; Stephen Gulyas; Yushan Liu; Karim A. Benhadji

Book ID: 119934824
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 119 KB
Volume: 9
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2009.n.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of alimta plus gemzar adm

Phase II trial of alimta plus gemzar administered every 21 days in patients with advanced pancreatic cancer

✍ Kindler, H.; Strickland, D.; Dugan, W.; Visconti, J.; Liebman, J.; Hochster, H.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Phase II study of doxorubicin plus ifosf

Phase II study of doxorubicin plus ifosfamide/mesna in patients with advanced breast cancer

✍ Michael J. Millward; Adrian L. Harris; Brian M. J. Cantwell 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 1 views

A phase II study of pemetrexed and carbo

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer

✍ August Garin; Alexey Manikhas; Mikhail Biakhov; Mikhail Chezhin; Tatiana Ivanche 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB

A phase II study of etoposide, cisplatin

A phase II study of etoposide, cisplatin plus methotrexate in patients with advanced refractory breast cancer

✍ Jouve, M.; Dorval, T.; Mosseri, V.; Palangie, T.; Beuzeboc, P.; Garcia-Giralt, E 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Randomized Phase II and Pharmacogenetic

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung Cancer

✍ Smit, E. F.; Burgers, S. A.; Biesma, B.; Smit, H. J.M.; Eppinga, P.; Dingemans, 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 181 KB

Primary chemotherapy with doxorubicin an

Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

✍ P. Schmid; J. Krocker; G. Morack; V. Heilmann; J.-U. Blohmer; K. Michniewicz; G. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 198 KB